Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novartis
Fierce Pharma
Lilly, Boehringer slash investment plans in Germany
In response to a healthcare reform initiative in Germany, Lilly and Boehringer have slashed their planned investments there, each by at least $1B.
Kevin Dunleavy
Jun 3, 2026 3:10pm
Novartis ‘always looking’ for new ways to shuttle drugs to brain
May 28, 2026 8:44am
Has Novartis’ T-Charge push been overtaken by in vivo CAR-Ts?
May 22, 2026 8:28am
Novartis trims ‘select number’ of biomedical research roles
May 15, 2026 10:58am
Novartis CEO ‘continuing to evaluate’ in vivo CAR-Ts
Apr 28, 2026 3:21am
Novartis narrows anticoagulant's focus after losing to Eliquis
Apr 22, 2026 4:00am
